Study of trofinetide in Rett syndrome: Lessons from an approved drug for a severe neurodevelopmental disorder

This commentary is on the original article by Cosand et al. on pages 407–417 of this issue.

Authors

Institutions

Publication Details

Journal
Developmental Medicine & Child Neurology
Published
2025-09-25
DOI
https://doi.org/10.1111/dmcn.70025
Primary Topic
Genetics and Neurodevelopmental Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Study of trofinetide in Rett syndrome: Lessons from an approved drug for a severe neurodevelopmental disorder

Walter E. Kaufmann
Developmental Medicine & Child Neurology
Genetics and Neurodevelopmental Disorders
article

Study of trofinetide in Rett syndrome: Lessons from an approved drug for a severe neurodevelopmental disorder

Walter E. Kaufmann
article en

Abstract

This commentary is on the original article by Cosand et al. on pages 407–417 of this issue.

Developmental Medicine & Child NeurologyVol. 68(3)
Boston Children's Hospital (US), Emory University (US)
Openalex Percentile: Top 72%
Genetics and Neurodevelopmental Disorders
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Study of trofinetide in Rett syndrome: Lessons from an approved drug for a severe neurodevelopmental disorder — Walter E. Kaufmann · Developmental Medicine & Child Neurology (2025) | TGRS Research Map | TGRS